The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease
- PMID: 23549610
- PMCID: PMC4875521
- DOI: 10.1007/s13238-013-2841-3
The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease
Similar articles
-
Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.Science. 2003 Jun 13;300(5626):1763-7. doi: 10.1126/science.1085658. Epub 2003 May 13. Science. 2003. PMID: 12746549
-
Drug design targeting the main protease, the Achilles' heel of coronaviruses.Curr Pharm Des. 2006;12(35):4573-90. doi: 10.2174/138161206779010369. Curr Pharm Des. 2006. PMID: 17168763 Review.
-
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11000-7. doi: 10.1073/pnas.96.20.11000. Proc Natl Acad Sci U S A. 1999. PMID: 10500114 Free PMC article.
-
Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors.FEBS Lett. 2007 Nov 27;581(28):5454-8. doi: 10.1016/j.febslet.2007.10.048. Epub 2007 Nov 5. FEBS Lett. 2007. PMID: 17981158 Free PMC article.
-
Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.Curr Pharm Des. 2006;12(35):4555-64. doi: 10.2174/138161206779010396. Curr Pharm Des. 2006. PMID: 17168761 Review.
Cited by
-
The missing link: covalent linkages in structural models.Acta Crystallogr D Struct Biol. 2021 Jun 1;77(Pt 6):727-745. doi: 10.1107/S2059798321003934. Epub 2021 May 19. Acta Crystallogr D Struct Biol. 2021. PMID: 34076588 Free PMC article.
-
Druggable targets from coronaviruses for designing new antiviral drugs.Bioorg Med Chem. 2020 Nov 15;28(22):115745. doi: 10.1016/j.bmc.2020.115745. Epub 2020 Sep 8. Bioorg Med Chem. 2020. PMID: 33007557 Free PMC article. Review.
-
Identifying structural-functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation.Mol Divers. 2022 Feb;26(1):309-329. doi: 10.1007/s11030-021-10220-8. Epub 2021 Apr 6. Mol Divers. 2022. PMID: 33825097 Free PMC article.
-
Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E.Virology. 2022 Jun;571:21-33. doi: 10.1016/j.virol.2022.04.005. Epub 2022 Apr 12. Virology. 2022. PMID: 35439707 Free PMC article.
-
Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold.Pharmaceuticals (Basel). 2022 Apr 27;15(5):540. doi: 10.3390/ph15050540. Pharmaceuticals (Basel). 2022. PMID: 35631367 Free PMC article.
References
-
- Lau SK, Li KS, Tsang AK, Shek CT, Wang M, et al. Recent transmission of a novel alphacoronavirus, bat coronavirus HKU10, from Leschenault’s Rousettes to Pomona leaf-nosed bats: first evidence of interspecies transmission of coronavirus between bats of different suborders. J Virol. 2012;86:11906–11918. doi: 10.1128/JVI.01305-12. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous